Stock Forecast Based On a Predictive Algorithm | I Know First |coronavirus stock market Archives - Stock Forecast Based On a Predictive Algorithm

Invest Properly During the Reopening With AI

This article was written by Gabriel Plat, a Financial Analyst at I Know First.

Subscribe to receive exclusive PREMIUM content here

This "Investment under the Coronavirus Pressure" article was written by Sergey Okun – Senior Financial Analyst, I Know First, Ph.D. in Economics.

The emergence the Omicron variant has significantly increased volatility in the market
The reaction of FED to Omicron is unclear now taking into account the inflation threat The annual i
The annual inflation rate in the US surged to 6.2% in October 2021

Subscribe to receive exclusive PREMIUM content here

The best hit Ratio is 100% for the 1-year time horizon for all stocks
SPY is reaching 100% accuracy for the 3-month time horizon
Our performance evaluation period covers the Covid-19 times, yet all the forecasts are still more than 51% accurate for all time horizons except Russell 2000 for the 7-day time horizon
I Know First provides an investment strategy for institutional investors that generated a return of 145.59% and exceeded the S&P 500 return by 100.1% for the analyzed period

The best hit Ratio is 100% for the 365-day time horizon both for QQQ and SPY ETFs
Russell 2000, Dow Jones transportation, and Dow Jones Industrial indexes' predictions are reaching 90%, 93% and 99% accuracy
Our performance evaluation period covers the Covid-19 times, yet all the forecasts are still more than 53% accurate for all time horizons.

I Know First Weekly Newsletter
Investment Selection Using AI Predictive Algorithm
December 23, 2020

This article was written by Gabriel Plat, a Financial Analyst at I Know First.

The vaccine is closer than we thought. Pfizer and BioNTech plan to distribute it by 2021;
AHT grew 228% in 3 days, indicating opportunities that might be available when the pandemic is over;
The entertainment and flight industries can be a huge opportunity to look at;
I Know First algorithm is the best way to maximize your profit amid these opportunities.

Subscribe to receive exclusive PREMIUM content here

The Tesla stock forecast was written by Hugh Camiener, Analyst at I Know First. Bachelor of Arts candidate at Columbia University.

Dynavax is a commercial state biopharmaceutical company which develops and commercializes vaccines..
Dynavax has an FDA approval on their Hepatitis B vaccine, and they have partnered with Sinovac in developing a vaccine for COVID.
The pandemic has caused a significant decline in Dynavax’s revenue, with their net product revenue falling 71% in comparison to Q2 last year.
Dynavax’s vaccine partnership with Sinovac has shown positive signs in phase 1 and phase 2 of testing, and their vaccine will be entering phase 3 in Brazil.
There is a large amount of volatility in the biopharmaceutical industry; amidst Russia’s self-proclaimed vaccine, Dynavax’s stock fell 9.7%.
Dynavax stock forecast remains a high-risk, high reward option..